GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:GSK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Feb 24	BuyUK£54,972	Jonathan Symonds	Individual	3,500	UK£15.71
01 Feb 24	BuyUK£306,430	Julie Brown	Individual	19,360	UK£15.83
20 Dec 23	BuyUK£28,907	Jonathan Symonds	Individual	2,000	UK£14.45
20 Dec 23	BuyUK£6,929	Urs Rohner	Individual	478	UK£14.50
20 Sep 23	BuyUK£28,994	Jonathan Symonds	Individual	1,900	UK£15.26
20 Sep 23	BuyUK£6,925	Urs Rohner	Individual	453	UK£15.29
23 Jun 23	BuyUK£86,387	Jonathan Symonds	Individual	6,000	UK£14.40
21 Jun 23	BuyUK£6,921	Urs Rohner	Individual	506	UK£13.68

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,876,139	0.0704%
Individual Insiders	4,560,407	0.112%
State or Government	8,424,577	0.206%
Private Companies	48,858,117	1.2%
Employee Share Scheme	82,340,591	2.02%
General Public	547,794,764	13.4%
Institutions	3,391,208,154	83%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 48.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.23%	Dodge & Cox	377,080,692	UK£6.0b	-0.58%	3.52%
8.17%	BlackRock, Inc.	333,814,330	UK£5.3b	-0.21%	0.12%
4.64%	The Vanguard Group, Inc.	189,450,566	UK£3.0b	2.2%	0.06%
2.35%	State Street Global Advisors, Inc.	96,070,919	UK£1.5b	1.91%	0.08%
2.21%	Norges Bank Investment Management	90,371,357	UK£1.4b	-4.83%	0.16%
2.08%	Legal & General Investment Management Limited	84,809,119	UK£1.3b	2.39%	0.36%
2.02%	GlaxoSmithKline Employee Trust	82,340,591	UK£1.3b	31.4%	no data
1.64%	Schroder Investment Management Limited	67,162,712	UK£1.1b	0.29%	0.9%
1.53%	UBS Asset Management AG	62,322,156	UK£990.9m	4.39%	0.18%
1.36%	Silchester International Investors LLP	55,504,791	UK£882.5m	0.15%	4.39%
1.32%	FMR LLC	53,986,854	UK£858.4m	10.4%	0.07%
1.2%	Mondrian Investment Partners Limited	49,224,258	UK£782.7m	0.16%	6.48%
1.19%	HSBC Global Asset Management (UK) Limited	48,492,384	UK£771.0m	11%	0.52%
1.18%	GlaxoSmithKline plc, Shareview Client	48,094,521	UK£764.7m	-0.9%	no data
1.11%	Columbia Management Investment Advisers, LLC	45,417,911	UK£722.1m	5.21%	0.23%
0.9%	Aviva Investors Global Services Ltd.	36,968,007	UK£587.8m	1.13%	1.09%
0.83%	Wellington Management Group LLP	33,808,189	UK£537.5m	-2.87%	0.11%
0.82%	Fisher Asset Management, LLC	33,317,889	UK£529.8m	1.06%	0.32%
0.8%	Franklin Resources, Inc.	32,752,139	UK£520.8m	4.69%	0.25%
0.75%	JP Morgan Asset Management	30,695,488	UK£488.1m	3.51%	0.08%
0.74%	Causeway Capital Management LLC	30,220,101	UK£480.5m	9.95%	2.72%
0.66%	Jupiter Fund Management Plc	26,807,896	UK£426.2m	-1.48%	1.41%
0.65%	Amundi Asset Management SAS	26,651,354	UK£423.8m	30.4%	0.11%
0.64%	T. Rowe Price Group, Inc.	26,192,730	UK£416.5m	1.11%	0.05%
0.61%	Northern Trust Global Investments	24,872,691	UK£395.5m	-3.18%	0.08%